KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) EBITDA: 2017-2025

Historic EBITDA for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to -$77.8 million.

  • Twist Bioscience's EBITDA rose 21.89% to -$26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.8 million, marking a year-over-year increase of 62.71%. This contributed to the annual value of -$77.8 million for FY2025, which is 62.70% up from last year.
  • As of FY2025, Twist Bioscience's EBITDA stood at -$77.8 million, which was up 62.70% from -$208.5 million recorded in FY2024.
  • Twist Bioscience's 5-year EBITDA high stood at -$77.8 million for FY2025, and its period low was -$220.3 million during FY2022.
  • Its 3-year average for EBITDA is -$163.3 million, with a median of -$203.5 million in 2023.
  • Its EBITDA has fluctuated over the past 5 years, first tumbled by 45.25% in 2022, then surged by 62.70% in 2025.
  • Over the past 5 years, Twist Bioscience's EBITDA (Yearly) stood at -$151.6 million in 2021, then tumbled by 45.25% to -$220.3 million in 2022, then grew by 7.59% to -$203.5 million in 2023, then dropped by 2.44% to -$208.5 million in 2024, then soared by 62.70% to -$77.8 million in 2025.